Early glycemic control reduces large-for-gestational-age infants in 250 Japanese gestational diabetes pregnancies.
Our objective was to test if tight glycemic control versus loose glycemic control in gestational diabetic patients and a gestational age of < 32 weeks influence fetal growth, fetal distress, and neonatal complication. We performed a retrospective study with 250 gestational diabetes mellitus in Japanese women. Two groups were categorized according to the timing at which good maternal glycemic control was attained at < 32 weeks and kept so until delivery (group 1) and > 32 weeks or never until delivery (group 2). In these two groups, neonatal growth (large-for-gestational age: LGA; appropriate- : AGA; and small- : SGA), neonatal complications (hypoglycemia, jaundice, polycythemia, and cumulative incidence), and incidence of fetal distress were compared. The chi2 test, unpaired t test, one-way analysis of variance (ANOVA) and multiple logistic regression analyses were used for statistical analyses. Maternal age, height, prepregnancy body mass index (BMI), gestational age at delivery were not different between the groups. In group 2 (> 32 weeks), LGA, macrosomia (> 4 kg), neonatal hypoglycemia was significantly increased compared with those in group 1. Incidence of SGA, fetal distress, and neonatal jaundice were not different between the groups. Multiple logistic regression analysis for LGA showed significant relation to timing of maternal glycemic control. We concluded that good glycemic control should be attained at < 32 weeks and maintained until delivery to reduce LGA infants and neonatal hypoglycemia in gestational diabetes mellitus. This management did not appear to decrease SGA infants or fetal distress.
Sameshima
H
H
Perinatal Center and Department of Obstetrics & Gynecology, Miyazaki Medical College, Kiyotake, Japan.
Kamitomo
M
M
Kajiya
S
S
Kai
M
M
Furukawa
S
S
Ikenoue
S
S
D000704:Analysis of Variance; D001724:Birth Weight; D001786:Blood Glucose / Q000032:analysis*; D016640:Diabetes, Gestational / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000517:prevention & control; D007564:Japan; D016015:Logistic Models; D011247:Pregnancy; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D012189:Retrospective Studies
D001786:Blood Glucose